Therefore, we selected CNR2, PPARA, PTGS1 and PTGS2, four key genes that have direct or indirect effects on prognosis in NSCLC, and conducted molecular docking with β-elemene. The gene discussed is PTGS1; the disease is non-small cell lung carcinoma.